1-4 of 4
Dominic Lai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) preferred fixed-duration treatments with less frequent administrations in the era of novel bispecific antibodies (BsAbs)

Free
Zachary Frosch, Anthony Masaquel, David Fox, Carolina Reyes, Lourenia Cassoli, Dominic Lai, Kelley Myers, Cooper Bussberg, Krish Patel
Journal: Blood
Blood (2025) 146 (Supplement 1): 6179.
https://doi.org/10.1182/blood-2025-6179
Published: 2025
Journal Articles

Healthcare Resource Utilization and Costs Associated with Obinutuzumab Plus Bendamustine Versus Rituximab Plus Bendamustine for First-Line Treatment of Follicular Lymphoma

Free
Tu My To, Jamie T. Ta, Arpamas Seetasith, Rongrong Wang, Dominic Lai, Sheila Shapouri
Journal: Blood
Blood (2021) 138 (Supplement 1): 3004.
https://doi.org/10.1182/blood-2021-145607
Published: 2021
Journal Articles

Treatment Patterns and Outcomes Among Patients with Relapsed/Refractory Follicular Lymphoma Treated in Routine Clinical Practice in the US with Three or More Lines of Therapy

Free
Jamie T. Ta, Stella Arndorfer, Cristina Julian, Mei Wu, Dominic Lai, Sheila Shapouri
Journal: Blood
Blood (2021) 138 (Supplement 1): 4080.
https://doi.org/10.1182/blood-2021-145412
Published: 2021
Journal Articles

Long-Term Efficacy of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL) With 4 Years of Follow-Up in Patients With TP53 Aberrations (del(17p) or TP53 Mutation): A Pooled Analysis From 4 Clinical Trials

Free
John N. Allan, MD, Tait Shanafelt, MD, Adrian Wiestner, MD PhD, Carol Moreno, MD PhD, Susan M. O'Brien, MD, Esteban Braggio, PhD, Emily Liu, MS, James P. Dean, MD PhD, Dominic Lai, PharmD, Inhye E. Ahn, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-134431
Published: 2020